Genome-wide association studies (GWAS) have linked EBF1 to multiple human cardiovascular disorders, including coronary heart disease 19-22, cardiovascular metabolic disease 23 and orthostatic hypotension 24, implying its potential roles in the human cardiac system. This evidence concerns the gene EBF1 and cardiovascular disorder.